These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 7528923

  • 1. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.
    Szabó C, Southan GJ, Thiemermann C.
    Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12472-6. PubMed ID: 7528923
    [Abstract] [Full Text] [Related]

  • 2. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity.
    Southan GJ, Szabó C, Thiemermann C.
    Br J Pharmacol; 1995 Jan 20; 114(2):510-6. PubMed ID: 7533622
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
    Wu CC, Chen SJ, Szabó C, Thiemermann C, Vane JR.
    Br J Pharmacol; 1995 Apr 20; 114(8):1666-72. PubMed ID: 7541282
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ.
    Br J Pharmacol; 1996 Aug 20; 118(7):1659-68. PubMed ID: 8842429
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. S-Methylisothiourea sulfate improves renal, but not hepatic dysfunction in canine endotoxic shock model.
    Mitaka C, Hirata Y, Masaki Y, Takei T, Yokoyama K, Imai T.
    Intensive Care Med; 2000 Jan 20; 26(1):117-24. PubMed ID: 10663292
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats.
    Vos TA, Gouw AS, Klok PA, Havinga R, van Goor H, Huitema S, Roelofsen H, Kuipers F, Jansen PL, Moshage H.
    Gastroenterology; 1997 Oct 20; 113(4):1323-33. PubMed ID: 9322528
    [Abstract] [Full Text] [Related]

  • 11. [Effects of selective nitric oxide synthase inhibitor in sheep with endotoxic shock].
    Liu D, Chen D, Qiu H.
    Zhonghua Yi Xue Za Zhi; 1996 Nov 20; 76(11):813-7. PubMed ID: 9275529
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase.
    Ruetten H, Southan GJ, Abate A, Thiemermann C.
    Br J Pharmacol; 1996 May 20; 118(2):261-70. PubMed ID: 8735625
    [Abstract] [Full Text] [Related]

  • 13. Thaliporphine selectively inhibits expression of the inducible, but not the constitutive, nitric oxide synthase.
    Yu SM.
    Biochem J; 1994 Oct 01; 303 ( Pt 1)(Pt 1):289-94. PubMed ID: 7524482
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock.
    Meng X, Ao L, Brown JM, Fullerton DA, Banerjee A, Harken AH.
    Shock; 1997 Feb 01; 7(2):111-8. PubMed ID: 9035287
    [Abstract] [Full Text] [Related]

  • 15. Tetramethylpyradizine prevents inducible NO synthase expression and improves survival in rodent models of endotoxic shock.
    Wu CC, Liao MH, Chen SJ, Yen MH.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct 01; 360(4):435-44. PubMed ID: 10551281
    [Abstract] [Full Text] [Related]

  • 16. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
    Thiemermann C, Ruetten H, Wu CC, Vane JR.
    Br J Pharmacol; 1995 Dec 01; 116(7):2845-51. PubMed ID: 8680715
    [Abstract] [Full Text] [Related]

  • 17. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction.
    Wildhirt SM, Suzuki H, Horstman D, Weismüller S, Dudek RR, Akiyama K, Reichart B.
    Circulation; 1997 Sep 02; 96(5):1616-23. PubMed ID: 9315556
    [Abstract] [Full Text] [Related]

  • 18. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C.
    Br J Pharmacol; 1996 Feb 02; 117(4):619-32. PubMed ID: 8646406
    [Abstract] [Full Text] [Related]

  • 19. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.
    Thiemermann C, Wu CC, Szabó C, Perretti M, Vane JR.
    Br J Pharmacol; 1993 Sep 02; 110(1):177-82. PubMed ID: 7693276
    [Abstract] [Full Text] [Related]

  • 20. S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction.
    Wildhirt SM, Suzuki H, Wolf WP, Dudek R, Horstman D, Weismueller S, Reichart B.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):328-33. PubMed ID: 8878517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.